CoreLink Announces Expanded Commercial Launch of FLXfit®15
CoreLink Surgical today announces the expanded commercial launch for the FLXfit®15 articulating-expandable intervertebral body fusion device.
CoreLink Surgical today announces the expanded commercial launch for the FLXfit®15 articulating-expandable intervertebral body fusion device.
CoreLink Surgical, LLC, Today Announced 510(k) Clearance to Market the M3 Stand-Alone Anterior Lumbar (ALIF) System.
CoreLink received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market The F3D Anterior Lumbar (ALIF) Interbody device.
CoreLink acquires Expanding Orthopedics Inc., including the FLXfit articulating and expanding interbody along with a portfolio of patents and products in development relating to expanding spinal implants.
Advanced additive manufacturing enables design innovations to drive improvements in spinal implant devices in CoreLink’s interbody systems.
Let CoreLink put the Insight, Performance, and Value of The Source to work for you.